Abbott Can't Escape FCA Suit Over Drug Marketing, Kickbacks
Law360, New York (January 31, 2014, 5:03 PM EST) -- A Pennsylvania federal judge refused Thursday to dismiss a former Abbott Laboratories employee’s suit claiming the company submitted false claims to government health programs by pushing its cholesterol drug TriCor for off-label uses and paying kickbacks to physicians.
In a 50-page memorandum, U.S. District Judge C. Darnell Jones II said that relator Amy Bergman “provides myriad details of Abbott’s marketing statements that contradict its FDA-approved label,” rejecting Abbott’s argument that the allegations of its False Claims Act violations are not specific enough to proceed.
Bergman, a former sales representative for Abbott, filed the complaint in September 2009 alleging she and other...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!